Riskpilot← Back to searchSign inGet full accessMEDIVIT ApS
APSDissolvedCVR 26515114Rosenkæret 11BWholesale of pharmaceutical and medical goods · NACE 4646Est. 20023 employees
Revenue 2020
DKK 1,3M
-22% vs 2019
EBITDA margin
65.5%
-7% vs 2019
Equity ratio
63.3%
Financial strength
Net profit 2020
DKK 629K
-8% vs 2019
| Revenue | DKK 1,3M | -22% |
| EBITDA | DKK 832K | -7% |
| Net profit | DKK 629K | -8% |
| Total assets | DKK 2,6M | +7% |
| Equity | DKK 1,7M | -5% |
| Employees | 3 | — |
Legal name
MEDIVIT ApS
CVR number
26515114
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
11. marts 2002
Share capital
DKK 125.000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2020-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af to direktører i forening eller af den samlede direktion.
Address
Rosenkæret 11B
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.417 | 1.868 | 2.407 | 2.722 | 2.508 | 2.407 | 1.869 | 1.626 | 1.270 |
| Staff expenses | -360 | -326 | -347 | -534 | -651 | -832 | -880 | -728 | -438 |
| EBITDA | 1.057 | 1.543 | 2.060 | 2.188 | 1.857 | 1.575 | 979 | 898 | 832 |
| Depreciation & amort. | 54 | 73 | 124 | -101 | -75 | -77 | -43 | -13 | -18 |
| EBIT | 1.004 | 1.470 | 1.937 | 2.087 | 1.782 | 1.498 | 936 | 885 | 814 |
| Net financials | -23 | -29 | -25 | 63 | -26 | -14 | -19 | -8 | -7 |
| Profit before tax | 980 | 1.441 | 1.911 | 2.150 | 1.755 | 1.484 | 917 | 878 | 807 |
| Tax | 246 | 361 | 484 | 504 | 427 | 333 | 180 | 197 | 178 |
| Net profit | 734 | 1.080 | 1.427 | 1.647 | 1.328 | 1.150 | 737 | 681 | 629 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3.891 | 3.709 | 5.004 | 5.006 | 4.771 | 3.958 | 2.464 | 2.467 | 2.637 |
| Equity | 2.388 | 2.277 | 2.569 | 2.889 | 2.651 | 2.413 | 1.940 | 1.766 | 1.670 |
| Long-term debt | 1.380 | 683 | 587 | 532 | 461 | 425 | 0 | 0 | 0 |
| Short-term debt | 812 | 749 | 1.840 | 1.577 | 1.659 | 1.121 | 523 | 701 | 964 |
| Total debt | 1.502 | 1.432 | 2.427 | 2.109 | 2.120 | 1.546 | 523 | 701 | 964 |
EBITDA margin
65.5%
This company
15.8%
Market median
+315% vs market
20122020
Equity ratio
63.3%
This company
38.2%
Market median
+66% vs market
20122020
Return on equity
37.7%
This company
18.4%
Market median
+105% vs market
20122020
Net profit margin
49.5%
This company
8.1%
Market median
+511% vs market
20122020
Asset turnover
0.48×
This company
1.12×
Market median
-57% vs market
20122020
Debt / equity
0.58×
This company
0.62×
Market median
+6% vs market
20122020
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EK Management | Management | 2009 | — | — |
HS Audit | Audit | 2002 | — | — |
SM Management | Management | 2012 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2005 | — | — | |
| Board of Directors | 2002 | — | — | |
| Board of Directors | 2002 | — | — | |
| Chairman | 2002 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
SPECIALLÆGESELSKABET KIRSTEN KROGH ApS | Company | 33.3% | 33.3% | 2012 |
| Individual | 25.0% | 25.0% | 2020 | |
KROFI ApS | Company | 50.0% | 50.0% | 2020 |
| Individual | 25.0% | 25.0% | 2020 | |
HELSEFARMA ApS | Company | 33.3% | 33.3% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEDIVIT ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Krogh | Management | 0 companies |
| Henning Siemsen | Audit | 0 companies |
| Steffen Møller | Management | 0 companies |
| Hans Christian Benedict Ahlefeldt-Laurvig | Board of Directors | 0 companies |
| Anne Marie Bachevold Svendsen | Board of Directors | 0 companies |
| Dorit Møller | Board of Directors | 0 companies |
| Kirsten Krogh | Chairman | 0 companies |